Growth Metrics

Corcept Therapeutics (CORT) Other Working Capital Changes (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Other Working Capital Changes for 15 consecutive years, with -$4.7 million as the latest value for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 135.02% year-over-year to -$4.7 million; the TTM value through Mar 2026 reached -$19.1 million, down 239.66%, while the annual FY2025 figure was -$829000.0, 1301.45% down from the prior year.
  • Other Working Capital Changes hit -$4.7 million in Q1 2026 for Corcept Therapeutics, up from -$16.5 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $16.0 million in Q3 2025 and bottomed at -$16.5 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is $505125.0, with a median of -$33000.0 recorded in 2022.
  • On a YoY basis, Other Working Capital Changes climbed as much as 18133.33% in 2025 and fell as far as 53396.77% in 2025.
  • Corcept Therapeutics' Other Working Capital Changes stood at -$10.4 million in 2022, then soared by 157.99% to $6.0 million in 2023, then tumbled by 99.49% to $31000.0 in 2024, then tumbled by 53396.77% to -$16.5 million in 2025, then soared by 71.34% to -$4.7 million in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$4.7 million, -$16.5 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.